Emanuela Zacco

Title: Emanuela Zacco: Innovator in Chimeric Antigen Receptors

Introduction

Emanuela Zacco is a prominent inventor based in Burlingame, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors (CARs). Her innovative work focuses on enhancing the effectiveness of targeted therapies in treating various diseases.

Latest Patents

Emanuela Zacco holds 1 patent for her invention titled "Fibronectin binding domain chimeric antigen receptors and methods of use thereof." This patent describes CARs designed for binding with target antigens, which include at least one antigen-specific targeting region comprising a fibronectin type 3 (FN3) domain polypeptide. Additionally, her work includes multispecific CARs that can bind with two or more target antigens, enhancing the potential for effective treatment options.

Career Highlights

Emanuela Zacco is currently associated with Protelica, Inc., where she continues to advance her research and development efforts. Her expertise in the field has positioned her as a key player in the biotechnology sector, contributing to innovative solutions for complex medical challenges.

Collaborations

Throughout her career, Emanuela has collaborated with notable professionals, including Roberto Crea and Jun Yoon. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in technology.

Conclusion

Emanuela Zacco's contributions to the field of chimeric antigen receptors exemplify her dedication to innovation in biotechnology. Her work not only advances scientific understanding but also holds the potential to improve therapeutic outcomes for patients.